The expression "You can't manage what you don't measure" is often attributed to management consultant Peter Drucker, though it's sometimes paraphrased as "You can't improve what you don't measure." The idea emphasises the importance of tracking and quantifying performance or outcomes to effectively manage or improve a process in healthcare.
Healthcare facility accreditation significantly enhances the quality and impact of breast cancer research, and many leading hospitals worldwide leverage their accredited status to drive advancements in this field. Facilities such as these are obliged to supply their research partners with standardised metrics like patient outcomes or treatment efficacy and one way to achieve this is via accreditation.
Accreditation ensures that healthcare facilities follow standardised protocols for patient care and data collection, resulting in higher-quality, more reliable, and consistent data. This is vital for breast cancer research, as researchers rely on accurate patient records, clinical data, and treatment outcomes to spot trends, assess therapies, and develop innovative interventions.
It’s a no-brainer that accredited hospitals and clinics use proven, evidence-based methods that lead to better patient outcomes. These improved results give researchers clearer insights into what treatments and approaches work best for breast cancer. Since accredited facilities follow consistent best practices, they reduce variations in care, making it easier for researchers to identify effective strategies.
Funding for research has always been a thorny issue. Research credibility depends on impartial funders.
Research, especially in fields like breast cancer, needs to stay independent and trustworthy. When corporations with financial interests—like drug companies or medical device manufacturers—get too involved, there’s a risk they’ll push for results that favour their products or profits over what’s best for patients. Accreditation helps keep things honest by enforcing strict standards for data collection and patient care, oversight by peer review and ensuring research is grounded in evidence, not corporate agendas. Accreditation systems enforce standardised, evidence-based protocols that safeguard data integrity and minimize bias.
In 2001, The New York Times reported on concerns about corporate influence in breast cancer research involving hormone replacement therapy (HRT). Wyeth-Ayerst, a pharmaceutical company, funded studies that promoted HRT’s benefits for menopausal women, downplaying its link to increased breast cancer risk. Critics, including women’s health advocates, argued the company’s funding biased the studies, emphasising positive effects while minimising risks, like a 26% increased breast cancer probability.
Accredited facilities uphold rigorous standards that help shield research from external pressures.
A way to relieve this pressure is that accreditation can make healthcare facilities eligible for grants, partnerships or participation in clinical trials. Funding bodies and research organisations often prioritise accredited facilities due to their demonstrated commitment to quality and safety, enabling them to contribute to or lead breast cancer studies.
Furthermore, accredited healthcare facilities adhere to strict ethical and regulatory standards, ensuring that breast cancer research conducted within these institutions meets high ethical benchmarks, protecting patients and enhancing the credibility of research outcomes.
It is a safe assumption that accredited facilities are more likely to meet the stringent requirements for conducting clinical trials. This allows them to participate in cutting-edge breast cancer research, testing new drugs, therapies, or diagnostic tools, which accelerates advancements in the field.
One of the most significant processes that emerges when a healthcare facility undergoes accreditation is that it leads to a heightened level of collaboration among departments like oncology, radiology and pathology. This This environment supports multidisciplinary research, enabling comprehensive studies on breast cancer that integrate genetics, imaging, and treatment outcomes.
Accreditation enhances patient trust, increasing participation in research studies or clinical trials. Higher patient engagement provides researchers with larger, more diverse sample sizes, improving the generalizability of findings.
Healthcare facility accreditation significantly enhances the quality and impact of breast cancer research, and many leading hospitals worldwide leverage their accredited status to drive advancements in this field.
Read more for for a thorough overview of breast cancer in South Africa.
For more information about accreditation in South Africa, have a look at www.cohsasa.co.za or email queries@cohsasa.co.za
